Pharma & Healthcare

Global Drug based on CAR T-Cell Market Research Report 2025

The global market for Drug based on CAR T-Cell was valued at US$ 414 million in the year 2024 and is projected to reach a revised size of US$ 660 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug based on CAR T-Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug based on CAR T-Cell.
The Drug based on CAR T-Cell market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug based on CAR T-Cell market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug based on CAR T-Cell companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Segment by Type
CD19-targeted
BCMA-targeted
Segment by Application
Lymphoma
Multiple Myeloma
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug based on CAR T-Cell company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug based on CAR T-Cell Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global Drug based on CAR T-Cell Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug based on CAR T-Cell Market Perspective (2020-2031)
2.2 Global Drug based on CAR T-Cell Growth Trends by Region
2.2.1 Global Drug based on CAR T-Cell Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug based on CAR T-Cell Historic Market Size by Region (2020-2025)
2.2.3 Drug based on CAR T-Cell Forecasted Market Size by Region (2026-2031)
2.3 Drug based on CAR T-Cell Market Dynamics
2.3.1 Drug based on CAR T-Cell Industry Trends
2.3.2 Drug based on CAR T-Cell Market Drivers
2.3.3 Drug based on CAR T-Cell Market Challenges
2.3.4 Drug based on CAR T-Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug based on CAR T-Cell Players by Revenue
3.1.1 Global Top Drug based on CAR T-Cell Players by Revenue (2020-2025)
3.1.2 Global Drug based on CAR T-Cell Revenue Market Share by Players (2020-2025)
3.2 Global Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug based on CAR T-Cell Revenue
3.4 Global Drug based on CAR T-Cell Market Concentration Ratio
3.4.1 Global Drug based on CAR T-Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug based on CAR T-Cell Revenue in 2024
3.5 Global Key Players of Drug based on CAR T-Cell Head office and Area Served
3.6 Global Key Players of Drug based on CAR T-Cell, Product and Application
3.7 Global Key Players of Drug based on CAR T-Cell, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug based on CAR T-Cell Breakdown Data by Type
4.1 Global Drug based on CAR T-Cell Historic Market Size by Type (2020-2025)
4.2 Global Drug based on CAR T-Cell Forecasted Market Size by Type (2026-2031)
5 Drug based on CAR T-Cell Breakdown Data by Application
5.1 Global Drug based on CAR T-Cell Historic Market Size by Application (2020-2025)
5.2 Global Drug based on CAR T-Cell Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug based on CAR T-Cell Market Size (2020-2031)
6.2 North America Drug based on CAR T-Cell Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug based on CAR T-Cell Market Size by Country (2020-2025)
6.4 North America Drug based on CAR T-Cell Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug based on CAR T-Cell Market Size (2020-2031)
7.2 Europe Drug based on CAR T-Cell Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug based on CAR T-Cell Market Size by Country (2020-2025)
7.4 Europe Drug based on CAR T-Cell Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug based on CAR T-Cell Market Size (2020-2031)
8.2 Asia-Pacific Drug based on CAR T-Cell Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug based on CAR T-Cell Market Size (2020-2031)
9.2 Latin America Drug based on CAR T-Cell Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug based on CAR T-Cell Market Size by Country (2020-2025)
9.4 Latin America Drug based on CAR T-Cell Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug based on CAR T-Cell Market Size (2020-2031)
10.2 Middle East & Africa Drug based on CAR T-Cell Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Drug based on CAR T-Cell Introduction
11.1.4 Novartis Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Drug based on CAR T-Cell Introduction
11.2.4 Gilead Sciences Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Introduction
11.3.4 Bristol-Myers Squibb Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Details
11.4.2 J & J Business Overview
11.4.3 J & J Drug based on CAR T-Cell Introduction
11.4.4 J & J Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Drug based on CAR T-Cell Introduction
11.5.4 JW Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Details
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite Drug based on CAR T-Cell Introduction
11.6.4 FOSUNKite Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Details
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Details
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Introduction
11.8.4 CARsgen Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Details
11.9.2 Autolus Therapeutics Business Overview
11.9.3 Autolus Therapeutics Drug based on CAR T-Cell Introduction
11.9.4 Autolus Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.9.5 Autolus Therapeutics Recent Development
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Details
11.10.2 Sorrento Therapeutics Business Overview
11.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Introduction
11.10.4 Sorrento Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.10.5 Sorrento Therapeutics Recent Development
11.11 Mustang Bio
11.11.1 Mustang Bio Company Details
11.11.2 Mustang Bio Business Overview
11.11.3 Mustang Bio Drug based on CAR T-Cell Introduction
11.11.4 Mustang Bio Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.11.5 Mustang Bio Recent Development
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Details
11.12.2 Bluebird Bio Business Overview
11.12.3 Bluebird Bio Drug based on CAR T-Cell Introduction
11.12.4 Bluebird Bio Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.12.5 Bluebird Bio Recent Development
11.13 Cellectis
11.13.1 Cellectis Company Details
11.13.2 Cellectis Business Overview
11.13.3 Cellectis Drug based on CAR T-Cell Introduction
11.13.4 Cellectis Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.13.5 Cellectis Recent Development
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Details
11.14.2 Allogene Therapeutics Business Overview
11.14.3 Allogene Therapeutics Drug based on CAR T-Cell Introduction
11.14.4 Allogene Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.14.5 Allogene Therapeutics Recent Development
11.15 Celyad
11.15.1 Celyad Company Details
11.15.2 Celyad Business Overview
11.15.3 Celyad Drug based on CAR T-Cell Introduction
11.15.4 Celyad Revenue in Drug based on CAR T-Cell Business (2020-2025)
11.15.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drug based on CAR T-Cell Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CD19-targeted
Table 3. Key Players of BCMA-targeted
Table 4. Global Drug based on CAR T-Cell Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug based on CAR T-Cell Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug based on CAR T-Cell Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug based on CAR T-Cell Market Share by Region (2020-2025)
Table 8. Global Drug based on CAR T-Cell Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug based on CAR T-Cell Market Share by Region (2026-2031)
Table 10. Drug based on CAR T-Cell Market Trends
Table 11. Drug based on CAR T-Cell Market Drivers
Table 12. Drug based on CAR T-Cell Market Challenges
Table 13. Drug based on CAR T-Cell Market Restraints
Table 14. Global Drug based on CAR T-Cell Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug based on CAR T-Cell Market Share by Players (2020-2025)
Table 16. Global Top Drug based on CAR T-Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2024)
Table 17. Ranking of Global Top Drug based on CAR T-Cell Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug based on CAR T-Cell Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug based on CAR T-Cell, Headquarters and Area Served
Table 20. Global Key Players of Drug based on CAR T-Cell, Product and Application
Table 21. Global Key Players of Drug based on CAR T-Cell, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug based on CAR T-Cell Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug based on CAR T-Cell Revenue Market Share by Type (2020-2025)
Table 25. Global Drug based on CAR T-Cell Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug based on CAR T-Cell Revenue Market Share by Type (2026-2031)
Table 27. Global Drug based on CAR T-Cell Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug based on CAR T-Cell Revenue Market Share by Application (2020-2025)
Table 29. Global Drug based on CAR T-Cell Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug based on CAR T-Cell Revenue Market Share by Application (2026-2031)
Table 31. North America Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug based on CAR T-Cell Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug based on CAR T-Cell Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug based on CAR T-Cell Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug based on CAR T-Cell Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug based on CAR T-Cell Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug based on CAR T-Cell Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug based on CAR T-Cell Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis Drug based on CAR T-Cell Product
Table 49. Novartis Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Gilead Sciences Company Details
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences Drug based on CAR T-Cell Product
Table 54. Gilead Sciences Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 55. Gilead Sciences Recent Development
Table 56. Bristol-Myers Squibb Company Details
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Drug based on CAR T-Cell Product
Table 59. Bristol-Myers Squibb Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. J & J Company Details
Table 62. J & J Business Overview
Table 63. J & J Drug based on CAR T-Cell Product
Table 64. J & J Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 65. J & J Recent Development
Table 66. JW Therapeutics Company Details
Table 67. JW Therapeutics Business Overview
Table 68. JW Therapeutics Drug based on CAR T-Cell Product
Table 69. JW Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 70. JW Therapeutics Recent Development
Table 71. FOSUNKite Company Details
Table 72. FOSUNKite Business Overview
Table 73. FOSUNKite Drug based on CAR T-Cell Product
Table 74. FOSUNKite Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 75. FOSUNKite Recent Development
Table 76. CARsgen Therapeutics (Pipeline) Company Details
Table 77. CARsgen Therapeutics (Pipeline) Business Overview
Table 78. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product
Table 79. CARsgen Therapeutics (Pipeline) Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 80. CARsgen Therapeutics (Pipeline) Recent Development
Table 81. CARsgen Therapeutics Company Details
Table 82. CARsgen Therapeutics Business Overview
Table 83. CARsgen Therapeutics Drug based on CAR T-Cell Product
Table 84. CARsgen Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 85. CARsgen Therapeutics Recent Development
Table 86. Autolus Therapeutics Company Details
Table 87. Autolus Therapeutics Business Overview
Table 88. Autolus Therapeutics Drug based on CAR T-Cell Product
Table 89. Autolus Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 90. Autolus Therapeutics Recent Development
Table 91. Sorrento Therapeutics Company Details
Table 92. Sorrento Therapeutics Business Overview
Table 93. Sorrento Therapeutics Drug based on CAR T-Cell Product
Table 94. Sorrento Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 95. Sorrento Therapeutics Recent Development
Table 96. Mustang Bio Company Details
Table 97. Mustang Bio Business Overview
Table 98. Mustang Bio Drug based on CAR T-Cell Product
Table 99. Mustang Bio Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 100. Mustang Bio Recent Development
Table 101. Bluebird Bio Company Details
Table 102. Bluebird Bio Business Overview
Table 103. Bluebird Bio Drug based on CAR T-Cell Product
Table 104. Bluebird Bio Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 105. Bluebird Bio Recent Development
Table 106. Cellectis Company Details
Table 107. Cellectis Business Overview
Table 108. Cellectis Drug based on CAR T-Cell Product
Table 109. Cellectis Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 110. Cellectis Recent Development
Table 111. Allogene Therapeutics Company Details
Table 112. Allogene Therapeutics Business Overview
Table 113. Allogene Therapeutics Drug based on CAR T-Cell Product
Table 114. Allogene Therapeutics Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 115. Allogene Therapeutics Recent Development
Table 116. Celyad Company Details
Table 117. Celyad Business Overview
Table 118. Celyad Drug based on CAR T-Cell Product
Table 119. Celyad Revenue in Drug based on CAR T-Cell Business (2020-2025) & (US$ Million)
Table 120. Celyad Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report


List of Figures
Figure 1. Drug based on CAR T-Cell Picture
Figure 2. Global Drug based on CAR T-Cell Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug based on CAR T-Cell Market Share by Type: 2024 VS 2031
Figure 4. CD19-targeted Features
Figure 5. BCMA-targeted Features
Figure 6. Global Drug based on CAR T-Cell Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug based on CAR T-Cell Market Share by Application: 2024 VS 2031
Figure 8. Lymphoma Case Studies
Figure 9. Multiple Myeloma Case Studies
Figure 10. Drug based on CAR T-Cell Report Years Considered
Figure 11. Global Drug based on CAR T-Cell Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Drug based on CAR T-Cell Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drug based on CAR T-Cell Market Share by Region: 2024 VS 2031
Figure 14. Global Drug based on CAR T-Cell Market Share by Players in 2024
Figure 15. Global Top Drug based on CAR T-Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Drug based on CAR T-Cell Revenue in 2024
Figure 17. North America Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Drug based on CAR T-Cell Market Share by Country (2020-2031)
Figure 19. United States Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Drug based on CAR T-Cell Market Share by Country (2020-2031)
Figure 23. Germany Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Drug based on CAR T-Cell Market Share by Region (2020-2031)
Figure 31. China Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Drug based on CAR T-Cell Market Share by Country (2020-2031)
Figure 39. Mexico Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Drug based on CAR T-Cell Market Share by Country (2020-2031)
Figure 43. Turkey Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Drug based on CAR T-Cell Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 47. Gilead Sciences Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 49. J & J Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 50. JW Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 51. FOSUNKite Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 52. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 53. CARsgen Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 54. Autolus Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 55. Sorrento Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 56. Mustang Bio Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 57. Bluebird Bio Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 58. Cellectis Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 59. Allogene Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 60. Celyad Revenue Growth Rate in Drug based on CAR T-Cell Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies